Investing.com - Financial Markets Worldwide

Sam Chun Dang Pharm Co Ltd (000250)

KOSDAQ
Currency in KRW
185,200
-900(-0.48%)
Closed·
000250 Scorecard
Full Analysis
Stock generally trades with high price volatility
000250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
185,200191,900
52 wk Range
88,200245,000
Key Statistics
Edit
Bid/Ask
185,200.00 / 185,700.00
Prev. Close
186,100
Open
191,800
Day's Range
185,200-191,900
52 wk Range
88,200-245,000
Volume
203.93K
Average Volume (3m)
247.05K
1-Year Change
22.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 14
Prominent player in the Pharmaceuticals industry
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Sam Chun Dang Pharm Co Ltd Company Profile

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
410
Market
South Korea

Compare 000250 to Peers and Sector

Metrics to compare
000250
Peers
Sector
Relationship
P/E Ratio
−372.0x14.6x−0.5x
PEG Ratio
20.94−0.230.00
Price/Book
16.4x1.0x2.6x
Price / LTM Sales
20.2x0.7x3.3x
Upside (Analyst Target)
-31.7%40.3%
Fair Value Upside
Unlock21.9%5.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -500.32%
Dividend Yield
0.11%
Industry Median 0.93%
Annualised payout
200.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
21.00 / --
Revenue / Forecast
50.62B / --
EPS Revisions
a
a
Unlock
Last 90 days

000250 Income Statement

People Also Watch

Doosan Heavy Ind. & Const.
65,500
034020
-1.50%
POSCO Holdings
307,500
005490
-0.49%
Kia Corp
103,700
000270
+0.48%
Hanwha Aerospace
883,000
012450
+0.57%
Hyundai Motor
217,500
005380
+0.69%

FAQ

What Stock Exchange Does Sam Chun Dang Pharm Trade On?

Sam Chun Dang Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Sam Chun Dang Pharm?

The stock symbol for Sam Chun Dang Pharm is "000250."

What Is the Sam Chun Dang Pharm Market Cap?

As of today, Sam Chun Dang Pharm market cap is 4.31T.

What Is Sam Chun Dang Pharm's Earnings Per Share (TTM)?

The Sam Chun Dang Pharm EPS (TTM) is -500.32.

When Is the Next Sam Chun Dang Pharm Earnings Date?

Sam Chun Dang Pharm will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is 000250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Sam Chun Dang Pharm Stock Split?

Sam Chun Dang Pharm has split 0 times.

How Many Employees Does Sam Chun Dang Pharm Have?

Sam Chun Dang Pharm has 410 employees.

What is the current trading status of Sam Chun Dang Pharm (000250)?

As of 16 Aug 2025, Sam Chun Dang Pharm (000250) is trading at a price of 185,200.00, with a previous close of 186,100.00. The stock has fluctuated within a day range of 185,200.00 to 191,900.00, while its 52-week range spans from 88,200.00 to 245,000.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.